Lobbying activity

Q1

BALLARD PARTNERS for THE CRANEWARE GROUP (F.K.A. SENTRY DATA SYSTEMS)

1st Quarter (Jan 1 - Mar 31) 2026 · Florida · $50,000.00 income

Health Issues, Pharmacy

View → Q1

PROFESSIONAL COMPOUNDING CENTERS OF AMERICA for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate

Pharmacy, Medicare/Medicaid, Budget/Appropriations

View → 1A

GENENTECH, INC for GENENTECH INC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Taxation/Internal Revenue Code, Pharmacy, Manufacturing, Immigration

View → Q1

STACEY BARRACK D/B/A STACEY BARRACK for VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES

1st Quarter (Jan 1 - Mar 31) 2026 · Ohio · House · Senate · $10,000.00 income

Pharmacy

View → Q1

GENENTECH, INC for GENENTECH INC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Pharmacy, Copyright/Patent/Trademark, Health Issues

View → Q1

DLA PIPER LLP (US) for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Budget/Appropriations, Defense, Trade (domestic/foreign)

View → Q1

BGR GOVERNMENT AFFAIRS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Pharmacy

View → Q1

DLA PIPER LLP (US) for BIOGEN, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues

View → Q1

MEHLMAN CONSULTING, INC. for ELEVANCE HEALTH, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Indiana · House · Senate · $90,000.00 income

Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code

View → Q1

THE VOGEL GROUP for NEPHRON PHARMACEUTICALS CORPORATION

1st Quarter (Jan 1 - Mar 31) 2026 · South Carolina · $50,000.00 income

Pharmacy

View → Q1

MILLER STRATEGIES, LLC for BLINK HEALTH INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · $90,000.00 income

Health Issues, Pharmacy

View → Q1

MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues, Pharmacy

View → Q1

MEHLMAN CONSULTING, INC. for AMERICA'S HEALTH INSURANCE PLANS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Pharmacy

View → Q1

MEHLMAN CONSULTING, INC. for AARP, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code, Retirement

View → Q1

UNIVERSITY OF IOWA for UNIVERSITY OF IOWA

1st Quarter (Jan 1 - Mar 31) 2026 · Iowa · House · Senate

Pharmacy, Roads/Highway, Small Business, Arts/Entertainment

View → Q1

HUMANA, INC. for HUMANA INC

1st Quarter (Jan 1 - Mar 31) 2026 · Kentucky · House · Senate

Medicare/Medicaid, Defense, Taxation/Internal Revenue Code, Pharmacy

View → 1A

WAXMAN STRATEGIES for 340B HEALTH

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $39,000.00 income

Health Issues, Pharmacy

View → Q1

WAXMAN STRATEGIES for 340B HEALTH

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $25,000.00 income

Health Issues, Pharmacy

View → Q1

AKIN GUMP STRAUSS HAUER & FELD for CENTRIENT PHARMACEUTICALS LLC

1st Quarter (Jan 1 - Mar 31) 2026 · California · Senate · $60,000.00 income

Manufacturing, Trade (domestic/foreign), Health Issues, Pharmacy

View → Q1

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate

Health Issues, Medicare/Medicaid, Pharmacy

View → Q1

THE WAYFINDER GROUP for YC CONSULTING, LLC ON BEHALF OF DISPOSE RX, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $10,000.00 income

Health Issues, Pharmacy

View → Q1

BUCHANAN INGERSOLL & ROONEY PC for VIDRINE PHARMACEUTICAL GROUP, LLC D/B/A BOUDREAUXS NEW DRUG STORE

1st Quarter (Jan 1 - Mar 31) 2026 · Louisiana · House · Senate · $40,000.00 income

Pharmacy

View → Q1

BUCHANAN INGERSOLL & ROONEY PC for UNIVERSITY OF PITTSBURGH MEDICAL CENTER HEALTH PLAN

1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $50,000.00 income

Budget/Appropriations, Health Issues, Insurance, Medicare/Medicaid

View → Q1

FARRAGUT PARTNERS LLP for ONEONCOLOGY INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Tennessee · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid, Pharmacy

View → Q1

BUCHANAN INGERSOLL & ROONEY PC for UNIVERSITY OF PITTSBURGH MEDICAL CENTER

1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $80,000.00 income

Medicare/Medicaid, Health Issues, Insurance, Budget/Appropriations

View →